Short Thesis Testing: Enterprise Software

The short thesis was simple: a once-sticky software platform was losing seats to a cheaper competitor, and net revenue retention was eroding faster than the company let on. Before sizing the position, the fund needed evidence from the company's own customers. Are they renewing, downgrading or leaving? The answer had to come from inside strict compliance limits.

Client
Equity hedge fund, multi-strategy
Sector
Enterprise software (public equity)
Engagement
Short-thesis validation
Timeline
2 weeks
01/

The Challenge

What was at stake

Reported metrics lagged reality, and management framed retention optimistically. The fund needed to test the core short thesis, accelerating churn and downgrades, with the people making the renewal decision. The risk was shorting on a narrative the customers would contradict.

02/

How We Approached It

4 steps
03/

What We Delivered

3 outputs
04/

Outcome

What it changed
9
Sources
2 weeks
Timeline
Net revenue retention
Focus
MNPI, per call
Screening
05/

In Their Words

Anonymised, role-based

The thesis was right in three segments and wrong in one. That nuance is the difference between a sized short and a blow-up. The customers told us before the print did.

Analyst
06/

Anonymity & Compliance

How this study was produced

This is a representative, anonymised composite of a typical hedge funds engagement. Client identity is removed and the figures illustrate the format and scale of the work. They are not a record of a single named mandate. Every expert call is scoped to general market knowledge, screened for material non-public information before findings reach a deal team, and documented for audit. See our compliance framework for full detail.

07/

Related Case Studies

3 similar
HF-01
L/S EQUITY · RETAIL CHANNEL CHECKS
Long/short equity fund, $2B AUM

A long/short fund tested a retailer's same-store-sales momentum with channel checks ahead of earnings.

HF-03
EVENT-DRIVEN · ANTITRUST READ
Event-driven fund, merger-arbitrage book

A merger-arb desk sized a spread using independent expert reads on the deal's antitrust odds.

VC-05
SERIES A LEAD · HEALTHTECH TEARDOWN
Sector-focused fund, $400M AUM

Before leading a healthtech Series A, a sector fund ran a teardown with the clinicians and buyers who actually evaluate the category.

Running the same decision? Brief us.

Response under 4 hours, Mon–Fri.
Contact Us
© 2026 Growth Insights Limited. All rights reserved.fieldsignalhq.com